Personalized AI Education Avatar for cancer treatment information

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study tests whether an AI-generated, patient-specific educational avatar paired with shorter nurse-led education can match standard education in helping patients recall information about their cancer treatment. The system uses physician-approved content and interactive video to deliver personalized information in Dutch to adults starting a new anti-cancer regimen at Erasmus MC. The trial focuses on recall of treatment details, safety instructions, and potential side effects, comparing it to usual education approaches. It leverages internet access and common devices, with recruitment limited to Dutch-speaking adults who can consent. The goal is to determine non-inferiority in recall while potentially reducing clinician workload.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged 18 years or older;
* Indication to start a new line of anti-cancer treatment at Erasmus MC Medical Oncology;
* Proficient in the Dutch language;
* Has access to the internet;
* Is capable using a digital device such as a computer, smartphone, or tablet;
* Able and willing to provide informed consent.

Exclusion Criteria:

* Has participated in this study for a previous line of anti-cancer treatment education.
* Significant cognitive impairment.
* Uncorrected visual or hearing impairment.

Where it's running

• Erasmus University Medical Centre
  Rotterdam, Netherlands Recruiting

Study contacts

• Study coordinator: Mark Mulder Medical-oncologist, MD, PhD
• Email: interne.oncology@erasmusmc.nl
• Phone: +31-10-7040704

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• SYMmetric Valve expansion to reduce hypoattenuated leaflet thickening after balloon-expandable TAVI

  This trial tests whether the Double-TAP post-dilatation strategy can reduce HALT and improve valve function in patients 70 or older undergoing balloon-expandable TAVI.

  Recruiting Erasmus Medical Center · Düsseldorf and 4 other locations · NCT07872020

• External warming to help septic patients without fever

  We’re testing whether warming the body externally can help people with sepsis who don’t have a fever.

  Recruiting Erasmus Medical Center · Rotterdam, South Holland · NCT07831057

• Turbine-based CO2 Insufflator in Pediatric Laparoscopy

  A new turbine-powered CO2 insufflator is being tested in children to see if it can maintain steadier abdominal pressures during laparoscopic surgery.

  Recruiting Erasmus Medical Center · Rotterdam, South Holland · NCT07715968

• Guideline Adherence in HFrEF: See If Mirror Information Helps Doctors and Patients Follow GDMT

  This study tests whether showing doctors, or both doctors and patients, mirror information about how well guideline-directed medical therapy is being used in heart failure with reduced ejection fraction.

  Recruiting Erasmus Medical Center · Rotterdam · NCT07702760

• Mild heat therapy added to standard treatment for locally advanced head and neck cancer

  This early-stage trial tests whether mild hyperthermia can be safely added to standard radiotherapy with or without chemotherapy for locally advanced head and neck cancer.

  Recruiting Phase 1 Erasmus Medical Center · Rotterdam, South Holland · NCT07690618

• Corticosteroid injections added to standard care for chronic midportion Achilles tendinopathy

  This trial tests whether 1–3 ultrasound-guided corticosteroid injections added to standard care help adults with long-standing midportion Achilles tendinopathy more than placebo injections plus standard care.

  Recruiting Phase 3 Erasmus Medical Center · Rotterdam · NCT07650396

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.